Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
<iframe src="https://statesidedaily.com/embed/cluster/7814a13b56b4572a6f19746eda9a55e335055a9e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement"></iframe>
